Prestige News

Total 66
Number Thumbnail Title Author Date Votes Views
56 IDC Expands Asset Value to Over 200 Billion KRW… "Accelerating Commercialization on the Back of Financial Stability"
we******** | 2026.05.11 | Votes 0 | Views 1077
we******** 2026.05.11 0 1077
55 BJFEZ Expands ‘Insight Trip’ Program to High School Students: “Discovering the Future On-Site”
we******** | 2026.04.29 | Votes 0 | Views 864
we******** 2026.04.29 0 864
54 Prestige Biopharma IDC Files Patent for Next-Generation Antibody Delivery Platform ‘IDC224’
김** | 2026.04.21 | Votes 0 | Views 1276
김** 2026.04.21 0 1276
53 BJFEZ Advances Open Innovation Campus for AI-Driven Drug Development
김** | 2026.04.13 | Votes 0 | Views 882
김** 2026.04.13 0 882
52 Prestige Biopharma's Avastin Biosimilar HD204 Nears Regulatory Approval and Commercialization
김** | 2026.03.24 | Votes 0 | Views 1566
김** 2026.03.24 0 1566
51 Prestige Biopharma IDC Signs Strategic Research Collaboration Agreement with Pusan National University Medical Research Institu
김** | 2026.02.25 | Votes 0 | Views 731
김** 2026.02.25 0 731
50 Prestige Biopharma IDC Files Patent for Bispecific Antibody Targeting Cytokine Storm–Related Inflammatory Diseases
김** | 2026.02.24 | Votes 0 | Views 731
김** 2026.02.24 0 731
49 Prestige Biopharma IDC Obtains ISO 9001 Certification for Global Quality Management System
김** | 2026.01.29 | Votes 0 | Views 581
김** 2026.01.29 0 581
48 Prestige Biopharma IDC Files Patent for PBP1710 Targeting Fibrotic Diseases
김** | 2026.01.23 | Votes 0 | Views 610
김** 2026.01.23 0 610
47 Prestige Biopharma Secures U.S. Patent for Novel Anticancer Antibody PBP1710
김** | 2025.12.08 | Votes 0 | Views 591
김** 2025.12.08 0 591